Literature DB >> 15943976

The anticoagulant protein C pathway.

Björn Dahlbäck1, Bruno O Villoutreix.   

Abstract

The anticoagulant protein C system regulates the activity of coagulation factors VIIIa and Va, cofactors in the activation of factor X and prothrombin, respectively. Protein C is activated on endothelium by the thrombin-thrombomodulin-EPCR (endothelial protein C receptor) complex. Activated protein C (APC)-mediated cleavages of factors VIIIa and Va occur on negatively charged phospholipid membranes and involve protein cofactors, protein S and factor V. APC also has anti-inflammatory and anti-apoptotic activities that involve binding of APC to EPCR and cleavage of PAR-1 (protease-activated receptor-1). Genetic defects affecting the protein C system are the most common risk factors of venous thrombosis. The protein C system contains multi-domain proteins, the molecular recognition of which will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943976     DOI: 10.1016/j.febslet.2005.03.001

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  80 in total

1.  Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1.

Authors:  Jong-Sup Bae; In-San Kim; Alireza R Rezaie
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells.

Authors:  Huang-Joe Wang; Te-Ling Lu; Haimei Huang; Huey-Chun Huang
Journal:  Tex Heart Inst J       Date:  2011

3.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

4.  Coagulation parameters and platelet function analysis in patients with acromegaly.

Authors:  A Colak; H Yılmaz; Y Temel; M Demirpence; N Simsek; İ Karademirci; U Bozkurt; E Yasar
Journal:  J Endocrinol Invest       Date:  2015-06-06       Impact factor: 4.256

5.  Manduca sexta proprophenoloxidase activating proteinase-3 (PAP3) stimulates melanization by activating proPAP3, proSPHs, and proPOs.

Authors:  Yang Wang; Zhiqiang Lu; Haobo Jiang
Journal:  Insect Biochem Mol Biol       Date:  2014-04-24       Impact factor: 4.714

6.  A thrombin inhibitor from the gut of Boophilus microplus ticks.

Authors:  Clarisse Gravina Ricci; Antônio Frederico Michel Pinto; Markus Berger; Carlos Termignoni
Journal:  Exp Appl Acarol       Date:  2007-08-21       Impact factor: 2.132

Review 7.  Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2013-11-12       Impact factor: 2.490

8.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

9.  Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients.

Authors:  Vitor Hugo Teixeira; Robert Olaso; Marie-Laure Martin-Magniette; Sandra Lasbleiz; Laurent Jacq; Catarina Resende Oliveira; Pascal Hilliquin; Ivo Gut; François Cornelis; Elisabeth Petit-Teixeira
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

10.  Analysis of endothelial protein C receptor functionality on living cells'.

Authors:  E Ducros; S Mirshahi; C Bermot; M Mirshahi
Journal:  Open Biochem J       Date:  2009-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.